Alex Diamantopoulos

8 Devonshire Square
London, ENG EC2M4PL, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Economic Burden of Idiopathic Pulmonary Fibrosis: Updated Evidence on Costs and Resource Use.

Economic Burden of Idiopathic Pulmonary Fibrosis: Updated Evidence on Costs and Resource Use.

Journal: PharmacoEconomics

Published: November 12, 2025

Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework.

Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework.

Journal: Advances in therapy

Published: October 15, 2021

The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe.

The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe.

Journal: PharmacoEconomics

Published: July 18, 2021

Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: A systematic review and meta-analysis.

Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: A systematic review and meta-analysis.

Journal: Comprehensive psychiatry

Published: August 30, 2019

Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation.

Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation.

Journal: BMJ open gastroenterology

Published: March 15, 2019

Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use.

Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use.

Journal: PharmacoEconomics - open

Published: June 27, 2018

The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Journal: PharmacoEconomics

Published: March 02, 2018

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: April 29, 2015

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.

Journal: PharmacoEconomics

Published: May 24, 2014

Validity of cost and utility results?

Validity of cost and utility results?

Journal: PharmacoEconomics

Published: August 10, 2012

Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy.

Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy.

Journal: Journal of medical economics

Published: February 09, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026